Global Nanomedicine Market – Size, Share and Forecast (2019-2026)

SKU: DHC44 | Published On: 2019-04-09 | Available Formats

Nanomedicine Market

  • Nanomedicine uses nanotechnology for the diagnosis, treatment, and prevention of disease and to gain an increased understanding of the complex underlying pathophysiology of the disease. Due to its minute size, nanomedicines can reach targets which are difficult to achieve through conventional methods with improved solubility and bioavailability and reduce adverse effects.
  • They also act as delivery agents by carrying both chemotherapeutics and imaging systems to the target site. Hence the nanomedicine can be used to attain the same therapeutic effect at smaller doses than their conventional counterparts and can offer impressive outputs for life-threatening diseases.
  • The global nanomedicine market was worth XX billion in 2018 and is forecasted to reach XX billion by 2026, at a CAGR of XX% during the forecast period.


Nanomedicine Market Drivers and Restraints

  • The rapid surge in applications of nanomedicine, broad acceptance of this products in therapeutic treatments and increase in the prevalence of cancer patients across the globe as these nanomedicines is considered as the significant line for treatment of cancer through targeted drug delivery are driving the global nanomedicine market during the forecast period.
  • Increase geriatric population and prevalence of chronic diseases including diabetes, obesity, orthopedic conditions, and kidney diseases are additionally driving the global nanomedicine market.
  • According to the American Institute of Cancer Research in 2018 estimated that approximately 18.1 million new cancer cases generated out of which 9.5 million are men, and 8.5 are women.
  • Traditionally surgery and radiotherapy have been the primary treatment, while anti-cancer cancer drugs are mainly being used in metastate cancer.
  • Over the years the chemotherapy has been successfully used for inhibiting cell growth, and side effects caused by the chemotherapy led the researchers to look for alternative medicine for all types of cancer. The nanoparticle is considered as one of the most potential options due to their ability to enhance the drug’s bioavailability.
  • Major factors hindering the global nanomedicine market are a high cost associated with the product since it is new technology, lack of awareness among the individuals and availability of alternatives for the products.


Nanomedicine Market Segmentation Analysis

  • Global nanomedicine market is segmented by product type, nano molecule type application type, and indication type. Product type includes diagnostics and therapeutics, nano molecule type includes nanoparticles, nanoshells, nanotubes, and hydrogel nanoparticles and application type includes drug delivery, diagnostic imaging, regenerative medicine, vaccines, implants, and others.
  • The indication type includes Cancer Treatment, Infectious diseases, Hepatitis, Cardiovascular diseases, immune disorders, degenerative disorders, and others.
  • Therapeutic segment dominated the global nanomedicine market during the forecast period due to significant products (drugs, devices and drug delivery systems) in nanomedicine fall under this category for treatment of several diseases.
  • Due to the unique properties exhibited by the nanoparticles, they serve as a promising technology for targeted drug delivery.


Global Nanomedicine Market Geographical Share

  • The global nanomedicine market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.
  • North America dominates the global nanomedicine market due to the presence of key players across the region, increase in establishments of startups in the field of nanomedicine for research and development of advanced technologies and increase in government and non-government funding for construction of nanomedicine and expected remain high during the forecast period.
  • Europe is expected to witness profitable growth during the forecast period due to the rise in some research grants and ongoing research on the development of novel technologies in the field of nanomedicine by research organizations.
  • In April 2018, Researchers at University of Lincoln UK, designed a new technique to decorate the gold nanoparticle with a protein of choice so they can be used to tailor a drug to more accurately target area on the body (cancer tumor).


Nanomedicine Market Competitive Trends

  • Recent FDA approvals, strategic collaboration between the key players and distributors for commercialization of their products and venture capitalist funding for key players for different development of nanomedicines are driving the global nanomedicine market.
  • In October 2018, Nanospectra Biosciences, Inc. a medical company pioneering novel use of nanomedicine for selective thermal ablation made a strategic partnership with Sebacia, Inc. and LiteCure, LLC, for the commercial launch of its products in the United States.
  • In August 2018, Blueberry Therapeutics Limited a drug discovery and development company focused on developing novel nano-medicines for difficult to treat skin and nail infections received 11.3 million USD funding from China Medical Venture Investment Limited.
  • In October 2018, FDA approved Coordinationation Pharmaceutical IND’s CP-100 a Novel Anti-tumor nanomedicine.
  • Major market players in the nanomedicine market are Ablynx, Abraxis, Celgene, Mallinckrodt, Merck, Pfizer, Nanosphere, Cytimmune Sciences, Nanospectra Biosciences, and Others.


Target Audience

  • Equipment Suppliers/ Buyers
  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Global Nanomedicine Market Scope

1. Nanomedicine Market – Scope and Methodology

1.1. Research Methodology

1.2. The Scope of the market

2. Nanomedicine Market – Industry Trends

3. Nanomedicine Market Outlook

3.1. Drivers

3.2. Restraints

3.3. Opportunity

3.4. Regulation

3.5. Supply Chain Analysis

3.6. Reimbursement policies

3.7. Technological Advancements

3.8. Porter’s Five Forces Analysis

4. Nanomedicine Market – Segmentation Analysis

4.1. By Product Type

4.1.1. Diagnostics

4.1.2. Therapeutics

4.2. By Nanomolecule Type

4.2.1. Nanoparticles Liposomes Polymer& Polymer drug conjugates Others

4.2.2. Nanoshells

4.2.3. Nanotubes

4.2.4. Hydrogel Nanoparticles

4.3. By Application

4.3.1. Drug delivery

4.3.2. Diagnostic imaging

4.3.3. Regenerative medicine

4.3.4. Vaccines

4.3.5. Implants

4.3.6. Others

4.4. By Indication

4.4.1. Cancer Treatment

4.4.2. Infectious diseases

4.4.3. Hepatitis

4.4.4. Cardiovascular diseases

4.4.5. Immune disorders

4.4.6. Degenerative disorders

4.4.7. Others

5. Nanomedicine Market – Regional, Country-level Analysis

5.1. Geographic Overview

5.2. North America

5.2.1. The U.S.

5.2.2. Mexico

5.2.3. Canada

5.3. Europe

5.3.1. Germany

5.3.2. The U.K.

5.3.3. France

5.3.4. Italy

5.3.5. Spain

5.3.6. Rest of Europe

5.4. South America

5.4.1. Brazil

5.4.2. Argentina

5.4.3. Rest of South America

5.5. Asia Pacific

5.5.1. China

5.5.2. India

5.5.3. Japan

5.5.4. Australia

5.5.5. Rest of Asia Pacific

5.6. Rest of World

6. Nanomedicine Market – Competitive Analysis

6.1. Competitive Scenario

6.2. Heat Map Analysis

6.3. Product Benchmarking

7. Nanomedicine Market – Company Profiles

7.1. Ablynx

7.2. Abraxis

7.3. Celgene

7.4. Mallinckrodt

7.5. Merck

7.6. Pfizer

7.7. Nanosphere

7.8. Cytimmune sciences

7.9. Nanospectra

7.10. Others

8. Nanomedicine Market – Key companies to watch

9. Nanomedicine Market – Emerging Companies

10. Nanomedicine Market – Appendix

10.1. Sources

10.2. List of Tables

10.3. Expert Panel Validation

10.4. Disclaimer

10.5. Contact Us

Buy This Report

Could not find what you need?

Quick Fact: 7 of 10 customers Tailor their reports

DMI Cognizance Expertise

Massive Repository

10-year historic data for 1000+ markets

Association Networks

Ground-Zero understanding of the market with inputs from relevant industry association members

First Hand Understanding

Tailored interviews with manufacturers, buyers, sellers, distributers and retailers for five-frame understanding of the market

360 Web Research

Analysis of publicly available white label papers, news announcements, press releases, financial reports and reliable paid consulting data

Star Expert Review

7-step data formulation for market analysis and forecasts, under thorough scrutiny of industry-specific consultants with over 20+ years of expertise


Copyright © 2019 DataM Intelligence. All Rights Reserved

Designed and Developed by -Montaigne Labs